Tibet Weixinkang Medicine Co., Ltd.

¥8.24As of Sun 8 Nov 2026, 12:00 UTC
SSE:603676Healthcare
Country China
PE (Fwd) •••
TSR 9Y CAGR (4.00%)
Div yield 3.97%
ROE 12.27%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) (0.02)
PE TTM 18.71
TSR TTM (23.46%)
Mkt cap ¥3.562B
ROIC 23.05%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥10
22.51%
(33.09%)
Hold 0|1|5|5|0
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.15
0.17
0.17
0.17
27.25%
27.42%
18.17%
26.33%
Revenue¥M
219.7
231.8
237.7
232.3
1.62%
8.11%
8.48%
6.96%
Peers (US$534.0M)
Cap (US$)
PE
537.6M
166.6x
537.1M
181.3x
Capital
TTM
5Y
10Y
Leveragex
0.210
0.481
0.452
EBIT/Intx
1.476
0.211
0.225
Own earn%
52.27
(29.52)
(25.73)
Sh yield%
54.54
29.36
27.96
Owners
Insiders/Inst%
2.48
57.87
Short interest%
0.54
SBC / revenue%
4.41
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
8
Op margin range%
19–24
$1 testx
—
Incr. ROIC%
1